Renaissance Technologies - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$393
+207.0%
125,200
+403.0%
0.00%
Q2 2023$128
-65.9%
24,893
-65.0%
0.00%
Q1 2023$375
-54.6%
71,193
-75.8%
0.00%
-100.0%
Q4 2022$826
-98.6%
293,993
+1887.4%
0.00%
Q3 2022$61,000
-96.0%
14,793
-96.1%
0.00%
-100.0%
Q2 2022$1,534,000
-39.3%
381,500
-25.3%
0.00%
-33.3%
Q1 2022$2,528,000
+353.0%
510,805
+537.7%
0.00%
+200.0%
Q4 2021$558,000
-77.3%
80,100
-67.5%
0.00%
-66.7%
Q3 2021$2,462,000
-46.9%
246,200
-24.7%
0.00%
-50.0%
Q2 2021$4,639,000
+466.4%
327,122
+555.6%
0.01%
+500.0%
Q1 2021$819,000
-88.2%
49,900
-85.1%
0.00%
-87.5%
Q4 2020$6,915,000
+738.2%
334,066
+275.8%
0.01%
+700.0%
Q1 2017$825,000
-32.0%
88,900
-38.7%
0.00%
-50.0%
Q4 2016$1,214,000
+418.8%
145,100
+206.8%
0.00%
Q2 2016$234,000
+1.3%
47,300
+330.3%
0.00%
-100.0%
Q2 2015$231,00010,9920.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders